3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
11
Lymphoma, Mantle-Cell
6
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Non-Hodgkin
5
Lymphoma
3
Waldenstrom Macroglobulinemia
2
Neoplasms
2
Burkitt Lymphoma
2
Bronchiolitis Obliterans Syndrome
2
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms, Castration-Resistant
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Prolymphocytic
1
Leukemia, Myeloid, Acute
1
Leukemia, Hairy Cell
1
Leukemia, B-Cell
1
Leukemia
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Anemia
1
Interventions
ruxolitinib
1
CPI-0610
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bone Marrow Diseases
×
ibrutinib
×
30 days
×
Clear all
No trials found.